Tirzepatide, a dual-action medication targeting both GIP and GLP-1 receptors, offers potentially superior metabolic benefits
In June 2025, the World Health Organization (WHO) warned that semaglutide drugs, such as Ozempic, Wegovy and Rybelsus, may rarely cause NAION
A third individual, a 33-year-old woman, reported going to the emergency room with nausea, vomiting, and abdominal after receiving what she believed to be semaglutide at an aesthetic spa
Finding the right semaglutide does for you takes time, but that balancebetween effectiveness and comfortis what keeps results steady and sustainable long term
Noom is offering Metformin to eligible new members this month and plans to offer it as an upgrade to eligible Noom Weight members in Q1 2025
If you encounter any GLP-1 product marketed in an unfamiliar format, ask the prescriber and pharmacy directly about sourcing, compounding standards, and what clinical evidence supports that delivery method